Alkermes, Biogen Partnering on Therapy for Relapsing Forms of Multiple Sclerosis
Alexa, News
Alkermes and Biogen have begun working together on a compound known as ALKS 8700 as a potential treatment for relapsing forms of multiple sclerosis.
Under the agreement, Alkermes will be responsible ... Read more